Effect of Body Mass Index on ICSI Outcomes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorAssiut University
About this trial
This retrospective cohort study aims to evaluate the effect of body mass index on the outcomes of intracytoplasmic sperm injection (ICSI) cycles at Assiut Women Health Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women who underwent ICSI cycles at Assiut Women Health Hospital
Recorded weight and height at the start of treatment
Disqualifiers
Cases with no recorded weight or height at registration
Trial population
Women who underwent intracytoplasmic sperm injection cycles at Assiut Women Health Hospital between January 2020 and December 2026.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
350 Participants
are grouped into 4 trial groupsGroup A: Underweight
Group B: Normal weight
Group C: Overweight
Group D: Obese
Trial outcomes
Primary outcomes
1
Clinical Pregnancy Rate After ICSI
Proportion of women achieving clinical pregnancy defined as positive serum beta-hCG and presence of gestational sac on ultrasound among total ICSI cycles stratified by BMI groups
Time frame
At 6 weeks after embryo transferSecondary outcomes
1
Ongoing Pregnancy Rate
Proportion of pregnancies continuing beyond 12 weeks gestation among women who achieved clinical pregnancy stratified by BMI groups
Time frame
At 12 weeks after embryo transfer2
Clinical Abortion Rate
Proportion of clinical pregnancies that result in pregnancy loss before 20 weeks gestation among BMI groups
Time frame
Up to 20 weeks after embryo transfer3
Live Birth Rate
Proportion of ICSI cycles resulting in live birth among BMI groups
Time frame
At 40 weeks after embryo transferLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: